Stanford Healthcare

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• High blood pressure3 trials
• Pulmonary arterial hypertension3 trials
• Huntington's disease1 trial

Phase

• Phase 34 trials

Status

• Completed2 trials
• Recruiting2 trials

Lead sponsor

• GB002, Inc.1 trial
• Gossamer Bio USA, Inc.1 trial
• Novartis Pharmaceuticals1 trial
• United Therapeutics1 trial

Running trials

• Recruiting

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Jessica Yankulova

• Recruiting

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  NCT06274801· Phase 3· Gossamer Bio USA, Inc.· Source

  Contact: GB002 Inc.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Huntington's disease1 recruiting
• Pulmonary arterial hypertension1 recruiting

Closed trials

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· GB002, Inc.· Source

• Completed

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· Phase 3· United Therapeutics· Source